Bristol Readies For Glucophage Generics: Adds 600 Reps, Refiles Vanlev
Bristol-Myers Squibb will expand its sales force in 2002 despite an expected $1.7 bil. drop in Glucophage revenues due to the launch of metformin generics
Bristol-Myers Squibb will expand its sales force in 2002 despite an expected $1.7 bil. drop in Glucophage revenues due to the launch of metformin generics